Project Details
Description
A Phase 2 Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
| Status | Active |
|---|---|
| Effective start/end date | 1/1/21 → 12/31/25 |
Funding
- PPD INVESTIGATOR SERVICES, LLC
- ARGENX
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.